Literature DB >> 32293548

Correction to: Does the preoperative platelet-tolymphocyte ratio and neutrophil-tolymphocyte ratio predict morbidity after gastrectomy for gastric cancer?

İbrahim Mungan1, Çilem Bayındır Dicle2, Şerife Bektaş2, Sema Sarı2, Serdar Yamanyar2, Mine Çavuş2, Sema Turan2, Erdal Birol Bostancı3.   

Abstract

In the original publication of this article [1] there are two garbled codes in the second sentence, the fourth paragraph of the Background section. The correct sentence should be: Tumor growth leads to the increased production of inflammatory cytokines and growth factors (mainly IL-1, IL-3, IL-6, IL-11, IL-23, and TNF-), and this perpetual process ensures immortality. These promoting factors are also important for angiogenesis and hematopoiesis, which explains the increase in blood cell types in cancerous diseases. The original publication has been corrected.

Entities:  

Year:  2020        PMID: 32293548      PMCID: PMC7087354          DOI: 10.1186/s40779-020-00242-y

Source DB:  PubMed          Journal:  Mil Med Res        ISSN: 2054-9369


Correction: Mil Med Res (2020) 7:9 https://doi.org/10.1186/s40779-020-00234-y In the original publication of this article [1] there are two garbled codes in the second sentence, the fourth paragraph of the Background section. The correct sentence should be: Tumor growth leads to the increased production of inflammatory cytokines and growth factors (mainly IL-1β, IL-3, IL-6, IL-11, IL-23, and TNF-α), and this perpetual process ensures immortality. These promoting factors are also important for angiogenesis and hematopoiesis, which explains the increase in blood cell types in cancerous diseases. The original publication has been corrected.
  1 in total

1.  Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?

Authors:  İbrahim Mungan; Çilem Bayındır Dicle; Şerife Bektaş; Sema Sarı; Serdar Yamanyar; Mine Çavuş; Sema Turan; Erdal Birol Bostancı
Journal:  Mil Med Res       Date:  2020-02-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.